Solid trials, solid medicine chttp://p4trc.emv2.com/HS?a=ENX7CqkWrP9- 8SA9MKJatd3nGHxKLTN8GPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMIEb> The ALTITUDE study (Aliskiren trial in type 2 diabetes using cardiorenal endpoints) underlines the critical importance of suitably powered trials with hard clinical endpoints in